shen211
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 14, 2023 (NCT06214858)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Replicase polyprotein 1abINHIBITOR
rep inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06288893 | Phase 2 | Apr 1, 2024 | Capital Medical University |
| NCT06214858 | Phase 1 | Dec 14, 2023 | University of Paris |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Paris | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1